Press release
Global Ebola Vaccine Market Expands: $173.82 Mn in 2024 to $288.41 Mn by 2033 | Johnson & Johnson, Merck & Co., Inc., GSK plc., CansinoBl0, and AIM ImmunoTech Inc.
The Global Ebola Virus Vaccine Market reached US$ 173.82 million in 2024 and is expected to reach US$ 288.41 million by 2033, growing at a CAGR of 6.4 % during the forecast period 2025-2033.Ebola Virus Vaccine Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/ebola-virus-vaccine-market?ch
The Ebola virus vaccine is a preventive measure designed to protect against Ebola virus disease, a severe and often fatal illness. The most widely used vaccine, rVSV-ZEBOV (Ervebo), is a live, recombinant vaccine that triggers an immune response against the Zaire Ebola virus strain. It has been used in outbreak responses and high-risk populations, significantly reducing transmission. Other vaccines are in development to provide broader protection against multiple Ebola virus strains.
List of the Key Players in the Ebola Virus Vaccine Market:
Johnson & Johnson, Merck & Co., Inc., GSK plc., CansinoBl0, and AIM ImmunoTech Inc.
Industry Development:
In June 2024, Gavi, the Vaccine Alliance, launched programs to introduce four additional vaccines in supported countries: preventive Ebola, human rabies (post-exposure prophylaxis), multivalent meningococcal conjugate, and hepatitis B birth dose. Initially approved by the Gavi Board, these initiatives were delayed due to the pandemic. The rollout aims to enhance immunization coverage and strengthen global health security.
Growth Forecast Projected:
The Global Ebola Virus Vaccine Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Ebola Virus Vaccine Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/ebola-virus-vaccine-market
Segment Covered in the Ebola Virus Vaccine Market:
By Strain Type: Zaire Ebolavirus, Sudan Virus, Taï Forest Virus, Others
By Vaccine Type: rVSV-ZEBOV, Ad26.ZEBOV and MVA-BN-Filo, Others
By End-User: Hospitals, Specialized Clinics, Others
Regional Analysis for Ebola Virus Vaccine Market:
The regional analysis of the Ebola Virus Vaccine Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/ebola-virus-vaccine-market
People Also Ask:
➠ What is the global sales, production, consumption, import, and export value of the Ebola Virus Vaccine market?
➠ Who are the leading manufacturers in the global Ebola Virus Vaccine industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?
➠ What opportunities and challenges do vendors in the global Ebola Virus Vaccine industry face?
➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?
➠ What are the key factors and limitations affecting the growth of the Ebola Virus Vaccine market?
➠ What are the various sales, marketing, and distribution channels in the global industry?
Browse More Reports: https://www.datamintelligence.com/research-report/ebola-virus-vaccine-market
Vaccines Market - https://www.datamintelligence.com/download-sample/vaccines-market?ch
Combination Vaccines Market - https://www.datamintelligence.com/download-sample/combination-vaccines-market?ch
Meningococcal Vaccines Market - https://www.datamintelligence.com/download-sample/meningococcal-vaccines-market?ch
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Ebola Vaccine Market Expands: $173.82 Mn in 2024 to $288.41 Mn by 2033 | Johnson & Johnson, Merck & Co., Inc., GSK plc., CansinoBl0, and AIM ImmunoTech Inc. here
News-ID: 3903914 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP

Fenoxaprop P Ethyl Herbicide Market Outlook: Crop Protection Innovation | Major …
Global Fenoxaprop P Ethyl Market reached US$ 202.87 million in 2022 and is expected to reach US$ 308.98 million by 2031, growing with a CAGR of 5.4% during the forecast period 2024-2031.
The Fenoxaprop P Ethyl Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including…

LPWAN Investment Surge: Why Businesses Are Turning to Low-Power Wide-Area Networ …
DataM Intelligence has published a new research report on "Low-Power Wide-Area Network Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report…

Military Robotics Market Report | Future of Defense Technology | Major Companies …
Global Military Robotics Market size reached US$ 18.98 billion in 2024 and is expected to reach US$ 34.82 billion by 2032, growing with a CAGR of 7.88% during the forecast period 2025-2032.
The Military Robotics Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their…

Future of Smart Food Packaging Industry Sector with Sensors, Indicators & Tracea …
DataM Intelligence has published a new research report on "Smart Food Packing Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report…
More Releases for Ebola
Ebola Vaccine Market Deep Research 2025-2032 | Ebola vaccine market are Merck an …
Latest Qualitative Research Report on the Ebola Vaccine Market Size 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research explores into the evolving Market's dynamics, value chain analysis, prominent investment areas, competitive landscape, drivers and constraints, regional outlook, and key market segments. It's also provides the industry overview with growth analysis and…
Ebola Virus Vaccine Market 2022 | Detailed Report
The Ebola Virus Vaccine research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the Ebola…
Ebola Vaccine Market Opportunity Analysis, 2018-2026
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus…
Ebola Treatment Market to Develop Rapidly by 2024
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash,…
Ebola Virus Vaccine Market & Pipeline Insight
Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which…
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola Hemorrhagic Fever) – Pipeline Review, H1 2017, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline landscape.
Ebola is a rare but deadly viral infection that…